Χώρα: Νέα Ζηλανδία
Γλώσσα: Αγγλικά
Πηγή: Medsafe (Medicines Safety Authority)
Haemophilus influenzae type b polysaccharide 10ug (conjugated to tetanus protein.); Bordetella Pertussis, inactivated 4 [iU]; Diphtheria toxoid, adsorbed 30 [iU]; Tetanus toxoid 60 [iU]
sanofi-aventis new zealand limited
Haemophilus influenzae type b polysaccharide 10 µg (conjugated to tetanus protein.)
Solution for injection
Active: Haemophilus influenzae type b polysaccharide 10ug (conjugated to tetanus protein.) Excipient: Sucrose TRIS-BP Active: Bordetella Pertussis, inactivated 4 [iU] Diphtheria toxoid, adsorbed 30 [iU] Tetanus toxoid 60 [iU] Excipient: Aluminium hydroxide Sodium chloride Thiomersal
Combination pack, prefilled syringe + vial,glass, 0.5 mL
Prescription
Prescription
Sanofi Pasteur SA
Package - Contents - Shelf Life: Combination pack, prefilled syringe + vial,glass - 0.5 mL - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Syringe, - 0.5 mL - - Vial, glass, - 1 dose units -
1992-12-24